Related Experiment Video
Updated: Sep 20, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.3K
Advances in Gynecological Cancers.
Michalis Liontos1, Oraianthi Fiste1, Flora Zagouri1
1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, 11528 Athens, Greece.
International Journal of Molecular Sciences
|June 10, 2022
Summary
Gynecological cancers significantly impact public health, causing mortality and substantial physical, emotional, and financial burdens. Addressing these challenges is crucial for individuals, caregivers, and communities worldwide.
Area of Science:
- Gynecological oncology
- Public health research
- Cancer epidemiology
Background:
- Gynecological cancers represent a major global health concern, contributing significantly to cancer mortality rates.
- The impact extends beyond physical health, encompassing severe emotional distress and considerable financial strain on patients, families, and healthcare systems.
- Understanding the multifaceted burden is essential for developing effective public health strategies and interventions.
Discussion:
- The economic consequences of gynecological cancers necessitate a comprehensive analysis of healthcare costs and productivity losses.
- Psychosocial support systems are vital for mitigating the emotional toll on patients and their support networks.
- Community-level interventions can play a role in early detection and improving patient outcomes.
Key Insights:
- Gynecological cancers impose a profound burden, affecting mortality, well-being, and economic stability.
- Multidisciplinary approaches are required to manage the complex challenges posed by these diseases.
- Public health initiatives must address the holistic needs of affected individuals and communities.
Outlook:
- Future research should focus on innovative prevention and treatment strategies to reduce the incidence and mortality of gynecological cancers.
- Enhanced screening programs and accessible supportive care are critical for improving patient quality of life.
- Policy-level changes are needed to ensure adequate resources for gynecological cancer research and patient support.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Vaccines
523
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
523
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K

